Cargando…
Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873691/ https://www.ncbi.nlm.nih.gov/pubmed/31753015 http://dx.doi.org/10.1186/s40880-019-0423-3 |
_version_ | 1783472717177028608 |
---|---|
author | Kimura, Hideharu Araya, Tomoyuki Yoneda, Taro Shirasaki, Hiroki Kurokawa, Koji Sakai, Tamami Koba, Hayato Tambo, Yuichi Nishikawa, Shingo Sone, Takashi Kasahara, Kazuo |
author_facet | Kimura, Hideharu Araya, Tomoyuki Yoneda, Taro Shirasaki, Hiroki Kurokawa, Koji Sakai, Tamami Koba, Hayato Tambo, Yuichi Nishikawa, Shingo Sone, Takashi Kasahara, Kazuo |
author_sort | Kimura, Hideharu |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6873691 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-68736912019-11-25 Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer Kimura, Hideharu Araya, Tomoyuki Yoneda, Taro Shirasaki, Hiroki Kurokawa, Koji Sakai, Tamami Koba, Hayato Tambo, Yuichi Nishikawa, Shingo Sone, Takashi Kasahara, Kazuo Cancer Commun (Lond) Letter to the Editor BioMed Central 2019-11-21 /pmc/articles/PMC6873691/ /pubmed/31753015 http://dx.doi.org/10.1186/s40880-019-0423-3 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Letter to the Editor Kimura, Hideharu Araya, Tomoyuki Yoneda, Taro Shirasaki, Hiroki Kurokawa, Koji Sakai, Tamami Koba, Hayato Tambo, Yuichi Nishikawa, Shingo Sone, Takashi Kasahara, Kazuo Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer |
title | Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer |
title_full | Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer |
title_fullStr | Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer |
title_full_unstemmed | Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer |
title_short | Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer |
title_sort | long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6873691/ https://www.ncbi.nlm.nih.gov/pubmed/31753015 http://dx.doi.org/10.1186/s40880-019-0423-3 |
work_keys_str_mv | AT kimurahideharu longlastingresponsesafterdiscontinuationofnivolumabtreatmentforreasonsotherthantumorprogressioninpatientswithpreviouslytreatedadvancednonsmallcelllungcancer AT arayatomoyuki longlastingresponsesafterdiscontinuationofnivolumabtreatmentforreasonsotherthantumorprogressioninpatientswithpreviouslytreatedadvancednonsmallcelllungcancer AT yonedataro longlastingresponsesafterdiscontinuationofnivolumabtreatmentforreasonsotherthantumorprogressioninpatientswithpreviouslytreatedadvancednonsmallcelllungcancer AT shirasakihiroki longlastingresponsesafterdiscontinuationofnivolumabtreatmentforreasonsotherthantumorprogressioninpatientswithpreviouslytreatedadvancednonsmallcelllungcancer AT kurokawakoji longlastingresponsesafterdiscontinuationofnivolumabtreatmentforreasonsotherthantumorprogressioninpatientswithpreviouslytreatedadvancednonsmallcelllungcancer AT sakaitamami longlastingresponsesafterdiscontinuationofnivolumabtreatmentforreasonsotherthantumorprogressioninpatientswithpreviouslytreatedadvancednonsmallcelllungcancer AT kobahayato longlastingresponsesafterdiscontinuationofnivolumabtreatmentforreasonsotherthantumorprogressioninpatientswithpreviouslytreatedadvancednonsmallcelllungcancer AT tamboyuichi longlastingresponsesafterdiscontinuationofnivolumabtreatmentforreasonsotherthantumorprogressioninpatientswithpreviouslytreatedadvancednonsmallcelllungcancer AT nishikawashingo longlastingresponsesafterdiscontinuationofnivolumabtreatmentforreasonsotherthantumorprogressioninpatientswithpreviouslytreatedadvancednonsmallcelllungcancer AT sonetakashi longlastingresponsesafterdiscontinuationofnivolumabtreatmentforreasonsotherthantumorprogressioninpatientswithpreviouslytreatedadvancednonsmallcelllungcancer AT kasaharakazuo longlastingresponsesafterdiscontinuationofnivolumabtreatmentforreasonsotherthantumorprogressioninpatientswithpreviouslytreatedadvancednonsmallcelllungcancer |